Friday, July 27, 2018

NervGen Pharma to take Case Western-developed nerve regeneration tech to market

The new technology, pioneered by researchers at Case Western Reserve School of Medicine, could improve the lives of millions of spinal cord injury patients.

from News from healthcareitnews.com https://ift.tt/2AdJlo9

0 comments:

Post a Comment